Episode: 46 - Eric Schadt on Building AI-Native Drug Development And Patient-Facing Care

Trends from the Trenches host Eleanor Howe sits down with computational biologist Eric Schadt—now an AI Scholar in Residence at Pfizer—who has spent 25 years pushing a simple idea with huge consequences: disease is a network property, not a single-gene problem. That mindset changes what “precision medicine” should mean, shifting the goal from better labels to better treatment decisions that actually improve outcomes for real patients. They get concrete about how the AI revolution...